Eli Lilly strikes a $3 billion Chinese drug deal

In April, President Trump signed an executive order slapping 100% tariffs on patented pharmaceutical imports. The idea: force drugmakers to bring manufacturing back to American soil — an America First bet that U.S. medicine should be made in the U.S.Two months later, one of the country's biggest pharmaceutical companies cut a nearly $3 billion deal with a company in Beijing.On Friday, Eli Lilly struck a research agreement with Beijing-based Haisco Pharmaceutical worth up to $3 billion — though n...